Discover
DNA
Ginkgo Bioworks Holdings, Inc.
7.89
1 x 7.52
1 x 8.67
bid
ask
+
0.34
4.50%
undefined @ 04:00 PM
7.77 -0.12 (1.52%)
| Ytd | -5.05% | |
| 1y | -40.90% |
7.43
day range
7.97
5.37
52 week range
17.58
| Open | 7.55 | Prev Close | 7.55 | Low | 7.43 | High | 7.97 | Mkt Cap | 515.41M |
| Vol | 704.07K | Avg Vol | 1.23M | EPS | -5.25 | P/E | -1.50 | Forward P/E | -1.19 |
| Beta | 1.77 | Short Ratio | 6.40 | Inst. Own | 68.36% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 8.77 | 200-d Avg | 9.14 | 1yr Est | 8.20 |
| Income Statement | |||
| Total Revenue | 19.47M | ||
| Revenues (USD) | 19.47M | ||
| Cost of Revenue | 3.10M | ||
| Gross Profit | 16.38M | ||
| Operating Expenses | 87.75M | ||
| Research and Development Expense | 49.92M | ||
| Selling, General and Administrative Expense | 37.83M | ||
| Operating Income | -71.37M | ||
| Income Tax Expense | -80.00K | ||
| Net Income | -82.59M | ||
| Net Income Common Stock | -82.59M | ||
| Net Income Common Stock (USD) | -82.59M | ||
| Consolidated Income | -82.59M | ||
| Net Income from Discontinued Operations | 6.53M | ||
| Earnings per Basic Share | -1.39 | ||
| Earnings per Basic Share (USD) | -1.39 | ||
| Earning Before Interest & Taxes (EBIT) | -82.67M | ||
| Earning Before Interest & Taxes (USD) | -82.67M | ||
| Weighted Average Shares | 59.56M | ||
| Balance Sheet | |||
| Cash and Equivalents | 143.86M | ||
| Cash and Equivalents (USD) | 143.86M | ||
| Investments | 244.30M | ||
| Investments Current | 229.59M | ||
| Investments Non-Current | 14.70M | ||
| Trade and Non-Trade Receivables | 20.27M | ||
| Current Assets | 409.96M | ||
| Property, Plant & Equipment Net | 516.82M | ||
| Total Assets | 1.03B | ||
| Total Debt | 410.70M | ||
| Current Liabilities | 79.60M | ||
| Debt Non-Current | 410.70M | ||
| Total Liabilities | 589.92M | ||
| Accumulated Retained Earnings (Deficit) | -6.23B | ||
| Accumulated Other Comprehensive Income | 1.19M | ||
| Shareholders Equity | 443.15M | ||
| Shareholders Equity (USD) | 443.15M | ||
| Assets Non-Current | 623.12M | ||
| Total Debt (USD) | 410.70M | ||
| Deferred Revenue | 92.81M | ||
| Goodwill and Intangible Assets | 48.86M | ||
| Liabilities Non-Current | 510.33M | ||
| Trade and Non-Trade Payables | 16.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.91M | ||
| Net Cash Flow from Financing | -19.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.70M | ||
| Capital Expenditure | -1.93M | ||
| Issuance (Repayment) of Debt Securities | -19.00K | ||
| Net Cash Flow from Investing | 23.13M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 25.02M | ||
| Net Cash Flow from Operations | -46.69M | ||
| Effect of Exchange Rate Changes on Cash | -129.00K | ||
| Share Based Compensation | 15.85M | ||